Danaher's Leica Division Closes Devicor Medical Products Buy

Danaher (NYSE:DHR) said today that its Leica Biosystems division closed its buyout of Devicor Medical Products, a developer of breast biopsy products.

Leica Biosystems specializes in automated cancer diagnostics. Financial terms were not disclosed.

Devicor, which has about 400 employees worldwide, was created by private equity firm GTCR. In 2010, the company acquired the Mammotome breast-care business from Johnson & Johnson (NYSE:JNJ), which it eventually expanded with new product lines and markets.

Help employers find you! Check out all the jobs and post your resume.

Back to news